The management of psychosis in movement disorder patients
- 1 May 2007
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 8 (7) , 935-943
- https://doi.org/10.1517/14656566.8.7.935
Abstract
(2007). The management of psychosis in movement disorder patients. Expert Opinion on Pharmacotherapy: Vol. 8, No. 7, pp. 935-943. doi: 10.1517/14656566.8.7.935Keywords
This publication has 90 references indexed in Scilit:
- Long-term Follow-up (24 Months) of Quetiapine Treatment in Drug-induced Parkinson Disease PsychosisClinical Neuropharmacology, 2006
- Combating psychosis in Parkinson’s disease patients: the use of antipsychotic drugsExpert Opinion on Investigational Drugs, 2006
- Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover studyJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 yearsMovement Disorders, 2004
- Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's diseaseMovement Disorders, 2003
- Risperidone in the treatment of psychoses in the elderly: a case report seriesEuropean Psychiatry, 2002
- Donepezil in the treatment of hallucinations and delusions in Parkinson’s diseaseNeurological Sciences, 2002
- Dementia with Lewy bodiesThe British Journal of Psychiatry, 2002
- Visual hallucinations in Parkinson's disease: a review and phenomenological surveyJournal of Neurology, Neurosurgery & Psychiatry, 2001
- A Study of Psychiatric Morbidity in Patients with Huntington's Disease, Their Relatives, and ControlsThe British Journal of Psychiatry, 1993